<sentence id="0">The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas .</sentence>
<sentence id="1">Our study was designed to clarify the significance of silencing the E-cadherin gene , which is located on 16q22.1 , due to CpG methylation during hepatocarcinogenesis .</sentence>
<sentence id="2">The CpG methylation status of primary hepatocellular carcinomas ( HCCs ) and corresponding liver tissues showing chronic hepatitis or cirrhosis , which are widely considered to be precancerous conditions , were assessed by digesting DNA with methylation-sensitive and non-sensitive restriction enzymes .</sentence>
<sentence id="3">CpG methylation around the promoter region of the E-cadherin gene was detected in 46 % of liver tissues showing chronic hepatitis or cirrhosis and 67 % of HCCs examined .</sentence>
<sentence id="4">Immunohistochemical examination revealed reduced E-cadherin expression in 59 % of HCCs examined .</sentence>
<sentence id="5">CpG methylation around the promoter region correlated significantly with reduced E-cadherin expression in HCCs ( p < 0.05 ) .</sentence>
<sentence id="6">CpG methylation around the promoter region , which increases during the progression from a precancerous condition to HCC , <scope type="spec" id="0"> <cue type="spec" id="0">may</cue> participate in hepatocarcinogenesis through reduction of E-cadherin expression , resulting in loss of intercellular adhesiveness and destruction of tissue morphology</scope> .</sentence>